# 68Ga-DOTA-Bombesin PET/MRI in Imaging Patients With Prostate Cancer

> **NCT02440308** · PHASE2 · COMPLETED · sponsor: **Stanford University** · enrollment: 10 (actual)

## Conditions studied

- Prostate Carcinoma

## Interventions

- **DRUG:** 68Ga-DOTA-Bombesin
- **PROCEDURE:** Magnetic Resonance Imaging (MRI) scan
- **PROCEDURE:** Positron Emission Tomography (PET) scan

## Key facts

- **NCT ID:** NCT02440308
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-04
- **Primary completion:** 2015-06-30
- **Final completion:** 2015-06-30
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2017-04-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02440308

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02440308, "68Ga-DOTA-Bombesin PET/MRI in Imaging Patients With Prostate Cancer". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT02440308. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*